Lista de obras -

A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.

artículo científico publicado en 2016

Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging

artículo científico publicado en 2018

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients

scientific article published on 18 March 2019

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.

artículo científico publicado en 2014

Development of Improved Double Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in PBMCs of Diabetic and Pre-frontal Cortex of Multiple Sclerosis Patients

scientific article published on 07 April 2020

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

scientific article published on 17 September 2019

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group

artículo científico publicado en 2020

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group

artículo científico publicado en 2021

Impact of CYP3A4 Genotype on Voriconazole Exposure

scientific article published on 29 August 2017

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice

artículo científico publicado en 2015

Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction

scientific article published on 03 July 2019

Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders

scientific article published on 25 July 2019

Multiple and Opposite Effects of Angiotensin II Receptor Blockers on the Bioavailability of Epoxyeicosatrienoic Acids

artículo científico publicado en 2017

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).

artículo científico publicado en 2017

Pharmacogénétique en cardiovasculaire : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx).

artículo científico publicado en 2017

Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors

artículo científico publicado en 2017

Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.

artículo científico publicado en 2018

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification

scientific article published on 17 June 2020

The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator?

artículo científico publicado en 2018

Lista de obras de

A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.

Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.

Development of Improved Double Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in PBMCs of Diabetic and Pre-frontal Cortex of Multiple Sclerosis Patients

Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group

Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group

Impact of CYP3A4 Genotype on Voriconazole Exposure

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice

Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction

Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders

Multiple and Opposite Effects of Angiotensin II Receptor Blockers on the Bioavailability of Epoxyeicosatrienoic Acids

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).

Pharmacogénétique en cardiovasculaire : état des connaissances et des pratiques – recommandations du Réseau national de pharmacogénétique (RNPGx).

Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors

Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification

The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator?